Accurate quantification of DNA methylation using combined bisulfite restriction analysis coupled with the Agilent 2100 Bioanalyzer platform

Nucleic Acids Research

Volumn 34, Issue 3, 2006, Pages

  Brena, Romulo Martin ^a,c   Auer, Herbert ^b   Kornacker, Karl ^c   Hackanson, Björn ^c,e   Raval, Aparna ^c   Byrd, John C ^d   Plass, Christoph ^c,f  

^a Department of Molecular Genetics ^*  (United States)

^b THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e UNIVERSITY OF FREIBURG   (Germany)

^f Medical Research Facility   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; GENOMIC DNA; RNA; 5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; DRUG DERIVATIVE; RESTRICTION ENDONUCLEASE; SULFITE;

ACCURACY; ANALYTICAL EQUIPMENT; ARTICLE; DNA ISOLATION; DNA METHYLATION; ELECTROPHORESIS; GENE AMPLIFICATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; RNA ISOLATION; SENSITIVITY ANALYSIS; CPG ISLAND; DIAGNOSTIC PROCEDURE; EVALUATION; INSTRUMENTATION; METHODOLOGY; MICROCHIP ELECTROPHORESIS; NEOPLASM; POLYMERASE CHAIN REACTION; REPRODUCIBILITY; TUMOR CELL LINE;

AZACITIDINE; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; DNA RESTRICTION ENZYMES; ELECTROPHORESIS, MICROCHIP; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASMS; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SULFITES;

EID: 33644861803     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gnj017     Document Type: Article

References (39)

1. Jones,P.A. and Laird,P.W. (1999) Cancer epigenetics comes of age. Nature Genet., 21, 163-167.
2. Jones,P.A. and Baylin,S.B. (2002) The fundamental role of epigenetic events in cancer. Nature Rev. Genet., 3, 415-428.
3. Clark,S.J., Harrison,J. and Frommer,M. (1995) CpNpG methylation in mammalian cells. Nature Genet., 10, 20-27.
4. Franchina,M. and Kay,P.H. (2000) Evidence that cytosine residues within 5′-CCTGG-3′ pentanucleotides can be methylated in human DNA independently of the methylating system that modifies 5′-CG-3′ dinucleotides. DNA Cell Biol., 19, 521-526.
5. Jabbari,K. and Bernardi,G. (2004) Cytosine methylation and CpG, TpG (CpA) and TpA frequencies. Gene, 333, 143-149.
6. Gardiner-Garden,M. and Frommer,M. (1987) CpG islands in vertebrate genomes. J. Mol. Biol., 196, 261-282.
7. Larsen,F., Gundersen,G., Lopez,R. and Prydz,H. (1992) CpG islands as gene markers in the human genome. Genomics, 13, 1095-1107.
8. Szyf,M., Pakneshan,P. and Rabbani,S.A. (2004) DNA demethylation and cancer: Therapeutic implications. Cancer Lett., 211, 133-143.
9. Baylin,S.B., Herman,J.G., Graff,J.R., Vertino,P.M. and Issa,J.P. (1998) Alterations in DNA methylation: A fundamental aspect of neoplasia. Adv. Cancer Res., 72, 141-196.
10. Bastian,P.J., Palapattu,G.S., Lin,X., Yegnasubramanian,S., Mangold,L.A., Trock,B., Eisenberger,M.A., Partin,A.W. and Nelson,W.G. (2005) Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy. Clin. Cancer Res., 11,4037-4043.
11. Friedrich,M.G., Chandrasoma,S., Siegmund,K.D., Weisenberger,D.J., Cheng,J.C., Toma,M.I., Huland,H., Jones,P.A. and Liang,G. (2005) Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma. Eur. J. Cancer, 41, 2769-2778.
12. Levenson,V.V. (2004) DNA methylation biomarkers of cancer: Moving toward clinical application. Pharmacogenomics., 5, 699-707.
13. Brock,M.V., Gou,M., Akiyama,Y., Muller,A., Wu,T.T., Montgomery,E., Deasel,M., Germonpre,P., Rubinson,L., Heitmiller,R.F. et al. (2003) Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma. Clin. Cancer Res., 9, 2912-2919.
14. Usadel,H., Brabender,J., Danenberg,K.D., Jeronimo,C., Harden,S., Engles,J., Danenberg,P.V., Yang,S. and Sidransky,D. (2002) Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res., 62, 371-375.
15. Maruyama,R., Toyooka,S., Toyooka,K.O., Harada,K., Virmani,A.K., Zochbauer-Muller,S., Farinas,A,J., Vakar-Lopez,F., Minna,J.D., Sagalowsky,A. et al. (2001) Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res., 61, 8659-8663.
16. Maruyama,R., Toyooka,S., Toyooka,K.O., Virmani,A.K., Zochbauer-Muller,S., Farinas,A.J., Minna,J.D., McConnell,J., Frenkel,E.P. et al. (2002) Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features. Clin. Cancer Res., 8, 514-519.
17. Fraga,M.F., Ballestar,E., Paz,M.F., Ropero,S., Setien,F., Ballestar,M.L., Heine-Suner,D., Cigudosa,J.C., Urioste,M., Benitez,J. et al. (2005) Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl Acad. Sci. USA, 102, 10604-10609.
18. Clark,S.J., Harrison,J., Paul,C.L. and Frommer,M. (1994) High sensitivity mapping of methylated cytosines. Nucleic Acids Res., 22, 2990-2997.
19. Xiong,Z. and Laird,P.W. (1997) COBRA: A sensitive and quantitative DNA methylation assay. Nucleic Acids Res., 25, 2532-2534.
20. Crocitto,L.E., Korns,D., Kretzner,L., Shevchuk,T., Blair,S.L., Wilson,T.G., Ramin,S.A., Kawachi,M.H. and Smith,S.S. (2004) Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results. Urology, 64, 821-825.
21. Lu,C.Y., Tso,D.J., Yang,T., Jong,Y.J. and Wei,Y.H. (2002) Detection of DNA mutations associated with mitochondrial diseases by Agilent 2100 bioanalyzer. Clin. Chim. Acta, 318, 97-105.
22. Panaro,N.J., Yuen,P.K., Sakazume,T., Fortina,P., Kricka,L.J. and Wilding,P. (2000) Evaluation of DNA fragment sizing and quantification by the agilent 2100 bioanalyzer. Clin. Chem., 46, 1851-1853.
23. Fuller,R.A., Clark,J., Kretzner,L., Korns,D., Blair,S.L., Crocitto,L.E. and Smith,S.S. (2003) Use of microfluidics chips for the detection of human telomerase RNA. Anal. Biochem., 313, 331-334.
24. Okazaki,Y., Okuizumi,H., Sasaki,N., Ohsumi,T., Kuromitsu,J., Hirota,N., Muramatsu,M. and Hayashizaki,Y. (1995) An expanded system of restriction landmark genomic scanning (RLGS Ver. 1.8). Electrophoresis, 16, 197-202.
25. Herman,J.G., Graff,J.R., Myohanen,S., Nelkin,B.D. and Baylin,S.B. (1996) Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc. Natl Acad. Sci. USA, 93, 9821-9826.
26. Li,L.C. and Dahiya,R. (2002) MethPrimer: Designing primers for methylation PCRs. Bioinformatics, 18, 1427-1431.
27. Tusnady,G.E., Simon,I., Varadi,A. and Aranyi,T. (2005) BiSearch: primer-design and search tool for PCR on bisulfite-treated genomes. Nucleic Acids Res., 33, e9.
28. Funes-Huacca,M., Regitano,L.C., Mueller,O. and Carrilho,E. (2004) Semiquantitative determination of Alicyclobacillus acidoterrestris in orange juice by reverse-transcriptase polymerase chain reaction and capillary electrophoresis - laser induced fluorescence using microchip technology. Electrophoresis, 25, 3860-3864.
29. Auer,H., Lyianarachchi,S., Newsom,D., Klisovic,M.I., Marcucci,G. and Kornacker,K. (2003) Chipping away at the chip bias: RNA degradation in microarray analysis. Nature Genet., 35, 292-293.
30. Raval,A., Lucas,D.M., Matkovic,J.J., Bennett,K.L., Liyanarachchi,S., Young,D.C., Rassenti,L., Kipps,T.J., Grever,M.R., Byrd,J.C. et al. (2005) TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia. J. Clin. Oncol., 23, 3877-3885.
31. Issa,J.P., Garcia-Manero,G., Giles,F.J., Mannari,R., Thomas,D., Faderl,S., Bayar,E., Lyons,J., Rosenfeld,C.S., Cortes,J. et al. (2004) Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies. Blood, 103, 1635-1640.
32. Cameron,E.E., Bachman,K.E., Myohanen,S., Herman,J.G. and Baylin,S.B. (1999) Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nature Genet., 21, 103-107.
33. Issa,J.P. (2000) CpG-island methylation in aging and cancer. Curr. Top. Microbiol. Immunol., 249, 101-118.
34. Gonzalgo,M.L. and Jones,P.A. (1997) Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE). Nucleic Acids Res., 25, 2529-2531.
35. Galm,O., Rountree,M.R., Bachman,K.E., Jair,K.W., Baylin,S.B. and Herman,J.G. (2002) Enzymatic regional methylation assay: A novel method to quantify regional CpG methylation density. Genome Res., 12, 153-157.
36. Boyd,V.L. and Zon,G. (2004) Bisulfite conversion of genomic DNA for methylation analysis: Protocol simplification with higher recovery applicable to limited samples and increased throughput. Anal. Biochem., 326, 278-280.
37. Colella,S., Shen,L., Baggerly,K.A., Issa,J.P. and Krahe,R. (2003) Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. Biotechniques, 35, 146-150.
38. Dupont,J.M., Tost,J., Jammes,H. and Gut,I.G. (2004) De novo quantitative bisulfite sequencing using the pyrosequencing technology. Anal. Biochem., 333, 119-127.
39. Toyooka,K.O., Toyooka,S., Maitra,A., Feng,Q., Kiviat,N.C., Smith,A., Minna,J.D., Ashfaq,R. and Gazdar,A.F. (2002) Establishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation. Am. J. Pathol., 161, 629-634.